Sam Brusco, Associate Editor01.26.22
Philips introduced a full-service, at-home, 12-lead electrocardiogram (ECG) tool to use in decentralized clinical trials. Data readings comparable to clinical, site-based ECGs are paired with Philips’ cloud-based data collection and analysis.
Clinical trial sponsors seeking regulatory approval for new therapies often face patient attrition, which can reduce quality of findings and lead to longer, more costly trials. By offering this technology at home, Philips hopes to boost trial recruitment, compliance, and retention through reducing the need for site visits.
“Our customers are seeking solutions that will help them to address key challenges that can stand in the way of extracting meaningful insights from their clinical trials,” Andy Broadway, General Manager of Ambulatory Monitoring and Diagnostics at Philips told the press. “Our growing portfolio of remote monitoring solutions help to curb patient attrition by reducing the amount of site visits required during the trial period, helping to improve both the quality of the outcome and the patient experience overall.”
Leveraging PCA 500 ECG patch data recording enables near real-time, secure data transmission without an onsite technician or home nurses.
The at-home, 12-lead ECG solution is now available in markets across North America, Europe, and Asia.
Clinical trial sponsors seeking regulatory approval for new therapies often face patient attrition, which can reduce quality of findings and lead to longer, more costly trials. By offering this technology at home, Philips hopes to boost trial recruitment, compliance, and retention through reducing the need for site visits.
“Our customers are seeking solutions that will help them to address key challenges that can stand in the way of extracting meaningful insights from their clinical trials,” Andy Broadway, General Manager of Ambulatory Monitoring and Diagnostics at Philips told the press. “Our growing portfolio of remote monitoring solutions help to curb patient attrition by reducing the amount of site visits required during the trial period, helping to improve both the quality of the outcome and the patient experience overall.”
Leveraging PCA 500 ECG patch data recording enables near real-time, secure data transmission without an onsite technician or home nurses.
The at-home, 12-lead ECG solution is now available in markets across North America, Europe, and Asia.